Stockscreener 앱 받기
7.24
5.73%
-0.44
전일 마감가:
$7.68
열려 있는:
$7.64
하루 거래량:
1.71M
Relative Volume:
1.03
시가총액:
$673.64M
수익:
$823.60M
순이익/손실:
$-116.00M
주가수익비율:
-5.5692
EPS:
-1.3
순현금흐름:
$-107.30M
1주 성능:
+9.53%
1개월 성능:
+20.07%
6개월 성능:
-30.45%
1년 성능:
-72.57%
1일 변동 폭
$7.22
$7.80
1주일 범위
$6.4002
$7.80
52주 변동 폭
$3.76
$29.30
Myriad Genetics Inc Stock (MYGN) Company Profile
명칭
Myriad Genetics Inc
전화
801-584-3600
주소
322 NORTH 2200 WEST, SALT LAKE CITY, UT
MYGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYGN
Myriad Genetics Inc
|
7.24 | 642.01M | 823.60M | -116.00M | -107.30M | -1.30 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-21 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-05-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-03-12 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-02-12 | 개시 | Craig Hallum | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-09 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-27 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-03 | 재개 | Jefferies | Underperform |
| 2024-05-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-12-21 | 재개 | Piper Sandler | Neutral |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Underweight |
| 2023-05-23 | 업그레이드 | Goldman | Sell → Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-10-06 | 개시 | Stephens | Equal-Weight |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Sell |
| 2019-09-26 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-08-14 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-08-02 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-08-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2019-07-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2019-03-12 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
| 2018-11-30 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-10-10 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-07-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-03-21 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2018-01-29 | 개시 | Goldman | Sell |
| 2018-01-22 | 재확인 | Barclays | Equal Weight |
| 2018-01-05 | 개시 | BTIG Research | Buy |
| 2017-10-02 | 재개 | Leerink Partners | Mkt Perform |
| 2017-08-09 | 재확인 | Barclays | Equal Weight |
| 2017-02-08 | 업그레이드 | Ladenburg Thalmann | Sell → Neutral |
| 2017-01-18 | 개시 | Deutsche Bank | Sell |
| 2016-10-10 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
모두보기
Myriad Genetics Inc 주식(MYGN)의 최신 뉴스
Dynamic Technology Lab Private Ltd Makes New $531,000 Investment in Myriad Genetics, Inc. $MYGN - MarketBeat
Graham Capital Management L.P. Acquires Shares of 71,349 Myriad Genetics, Inc. $MYGN - MarketBeat
Myriad Genetics, Inc. $MYGN Shares Sold by Cubist Systematic Strategies LLC - MarketBeat
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD - MSN
Several Myriad Genetics Insiders Sell Shares Sending Potential Negative Signal - 富途牛牛
What’s the outlook for Myriad Genetics Inc.’s sectorWeekly Trend Summary & Low Risk Growth Stock Ideas - Lancaster City Council
PDT Partners LLC Buys Shares of 96,434 Myriad Genetics, Inc. $MYGN - MarketBeat
Is It Too Early to Call Recovery in Myriad Genetics Inc.Weekly Investment Summary & Free Community Consensus Stock Picks - beatles.ru
How liquid is Myriad Genetics Inc. stock2025 Key Lessons & Long-Term Safe Investment Ideas - beatles.ru
Myriad Genetics Inc. Shows Risk Reward Favoring Upside2025 Breakouts & Breakdowns & Free Technical Pattern Based Buy Signals - beatles.ru
Myriad Genetics (NASDAQ:MYGN) Trading Up 6.4%Still a Buy? - MarketBeat
Analyzing Myriad Genetics Inc. with multi timeframe chartsEarnings Beat & Stock Portfolio Risk Control - Newser
Will Myriad Genetics Inc. see short term momentumCEO Change & Entry Point Strategy Guides - Newser
Combining price and volume data for Myriad Genetics Inc.July 2025 Levels & Real-Time Buy Signal Alerts - Newser
Is Myriad Genetics Inc. attractive at current valuation2025 Trading Volume Trends & Accurate Buy Signal Alerts - خودرو بانک
Relative strength of Myriad Genetics Inc. in sector analysisWeekly Gains Report & Fast Exit Strategy with Risk Control - Newser
What are Myriad Genetics Inc.’s technical support levels2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - خودرو بانک
Fed Meeting: Can Myriad Genetics Inc. outperform under higher oil pricesQuarterly Trade Summary & AI Forecasted Entry/Exit Points - خودرو بانک
Is Myriad Genetics Inc. stock entering bullish territoryInflation Watch & Risk Adjusted Swing Trade Ideas - Newser
Momentum divergence signals in Myriad Genetics Inc. chart2025 Growth vs Value & Real-Time Volume Triggers - Newser
How moving averages guide Myriad Genetics Inc. tradingCEO Change & Consistent Profit Trade Alerts - Newser
MYGN's GeneSight Test Proven Superior to TAU: Stock to Gain? - Yahoo Finance
Insight Molecular Diagnostics Inc. shares rise 1.62% premarket after Myriad Genetics announces positive MRD test results. - AInvest
Best data tools to analyze Myriad Genetics Inc. stock2025 Big Picture & Safe Capital Growth Tips - Newser
Is Myriad Genetics Inc. showing signs of accumulationQuarterly Risk Review & Real-Time Buy Zone Alerts - Newser
How to integrate Myriad Genetics Inc. into portfolio analysis toolsMarket Movers & Growth Focused Stock Pick Reports - Newser
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology - GlobeNewswire
Myriad Genetics at Wells Fargo Conference: Growth Strategy Unveiled By Investing.com - Investing.com Canada
Myriad Genetics' Precise MRD Test Demonstrates Effective Detection of ctDNA in Oligometastatic Clear-Cell Renal Cell Carcinoma Patients - Quiver Quantitative
Myriad Genetics at Wells Fargo Conference: Growth Strategy Unveiled - Investing.com
How does Myriad Genetics Inc. compare to its peersQuarterly Performance Summary & Reliable Price Breakout Alerts - خودرو بانک
How to monitor Myriad Genetics Inc. with trend dashboardsWeekly Volume Report & Free Community Consensus Stock Picks - Newser
Myriad Genetics Inc. stock prediction for this weekJuly 2025 Sector Moves & Safe Swing Trade Setups - Newser
What recovery options are there for Myriad Genetics Inc.July 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Jump Financial LLC Purchases New Stake in Myriad Genetics, Inc. $MYGN - MarketBeat
Analyzing recovery setups for Myriad Genetics Inc. investorsPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
New Meta-Analysis Demonstrates that Access to the GeneSight - GlobeNewswire
What analysts say about Myriad Genetics Inc. stockTrade Performance Summary & Daily Momentum Trading Reports - خودرو بانک
New meta-analysis demonstrates that access to the GeneSight test can significantly improve response and remission rates for patients with depression - MarketScreener
Myriad Genetics Announces Meta-Analysis Results Indicating GeneSight Test Enhances Remission and Response Rates in Major Depressive Disorder Patients - Quiver Quantitative
Using portfolio simulators with Myriad Genetics Inc. includedQuarterly Trade Summary & High Win Rate Trade Tips - Newser
Will Myriad Genetics Inc. continue its uptrendJuly 2025 Closing Moves & Community Verified Trade Signals - Newser
How to use Fibonacci retracement on Myriad Genetics Inc.Quarterly Portfolio Review & Consistent Growth Equity Picks - Newser
Combining machine learning predictions for Myriad Genetics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
41% Higher Depression Remission: Myriad Genetics' GeneSight Test Proves Superior in 3,500+ Patient Study - Stock Titan
Myriad Genetics Inc (MYGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.33%
자본화:
|
볼륨(24시간):